Michael Deeds

954 total citations · 1 hit paper
14 papers, 668 citations indexed

About

Michael Deeds is a scholar working on Surgery, Oncology and Physiology. According to data from OpenAlex, Michael Deeds has authored 14 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Oncology and 4 papers in Physiology. Recurrent topics in Michael Deeds's work include Pancreatic function and diabetes (4 papers), Biomedical Ethics and Regulation (3 papers) and Immunotherapy and Immune Responses (3 papers). Michael Deeds is often cited by papers focused on Pancreatic function and diabetes (4 papers), Biomedical Ethics and Regulation (3 papers) and Immunotherapy and Immune Responses (3 papers). Michael Deeds collaborates with scholars based in United States. Michael Deeds's co-authors include Yogish C. Kudva, Adam Armstrong, Norman L. Eberhardt, Jill Anderson, Henry J. Hiddinga, Dennis A. Gastineau, Arshad Jahangir, Toshie Sakuma, Yasuhiro Ikeda and Tayaramma Thatava and has published in prestigious journals such as Blood, Neurology and Transplantation.

In The Last Decade

Michael Deeds

13 papers receiving 660 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models

2011 455 citations Michael Deeds, Jill Anderson et al. Laboratory Animals profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Deeds United States	6	245	223	218	109	107	14	668
Adam Armstrong United States	5	330 1.3×	194 0.9×	260 1.2×	89 0.8×	102 1.0×	9	761
Terumasa Nagase Japan	16	297 1.2×	145 0.7×	137 0.6×	95 0.9×	215 2.0×	28	754
G. Sachse United Kingdom	10	408 1.7×	209 0.9×	210 1.0×	89 0.8×	168 1.6×	19	792
Johanna Henriksnäs Sweden	12	228 0.9×	139 0.6×	361 1.7×	124 1.1×	64 0.6×	18	672
Tamara Saksida Serbia	18	263 1.1×	96 0.4×	104 0.5×	92 0.8×	57 0.5×	50	831
Chintan N. Koyani Austria	14	403 1.6×	163 0.7×	114 0.5×	37 0.3×	86 0.8×	19	830
César Tadeu Spadella Brazil	15	147 0.6×	196 0.9×	127 0.6×	47 0.4×	96 0.9×	54	671
Alessandra Puddu Italy	16	403 1.6×	244 1.1×	159 0.7×	60 0.6×	218 2.0×	38	859
Ho Seon Park South Korea	21	546 2.2×	231 1.0×	299 1.4×	104 1.0×	208 1.9×	38	1.1k
Traci E. LaMoia United States	6	391 1.6×	198 0.9×	144 0.7×	33 0.3×	141 1.3×	8	690

Countries citing papers authored by Michael Deeds

Since Specialization

Citations

This map shows the geographic impact of Michael Deeds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Deeds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Deeds more than expected).

Fields of papers citing papers by Michael Deeds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Deeds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Deeds. The network helps show where Michael Deeds may publish in the future.

Co-authorship network of co-authors of Michael Deeds

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Deeds. A scholar is included among the top collaborators of Michael Deeds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Deeds. Michael Deeds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

DiGuardo, Margaret, Michael Deeds, Timothy D. Wiltshire, et al.. (2025). Fellowship training for cellular therapy laboratory directors. Cytotherapy. 27(5). 642–648. 1 indexed citations

Staff, Nathan P., Björn Oskarsson, Nicolas N. Madigan, et al.. (2024). Results from a Phase 2 Clinical Trial of Repeated Intrathecal Autologous Adipose-derived MSCs in ALS (S5.004). Neurology. 102(7_supplement_1).

Wiltshire, Timothy D., Michael Deeds, Darcie J. Radel, et al.. (2021). Management of externally manufactured cell therapy products: the Mayo Clinic approach. Cytotherapy. 24(1). 19–26. 3 indexed citations

Lin, Yi, Marta Marin‐Argany, Christopher J. Dick, et al.. (2017). Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damage. Cytotherapy. 19(12). 1426–1437. 12 indexed citations

Dietz, Allan B., André J. van Wijnen, Greg W. Butler, et al.. (2017). A consistent, and predictable drug: The first 100 patients treated with autologous adipose derived mesenchymal stromal cells (MSCs) at the Mayo Clinic. Cytotherapy. 19(5). S155–S155. 1 indexed citations

Lin, Yi, Thomas D. Atwell, Adam J. Weisbrod, et al.. (2015). Dendritic cell vaccine treatment for indolent B-cell non-Hodgkin lymphoma: clinical trial in progress. Cytotherapy. 17(6). S17–S17. 2 indexed citations

Atwell, Thomas D., Adam J. Weisbrod, Mary Maas, et al.. (2014). Dendritic Cell Vaccine Treatment for B-Cell Non-Hodgkin Lymphoma: Clinical Trial in Progress. Blood. 124(21). 4474–4474. 3 indexed citations

Tonne, Jason M., Toshie Sakuma, Michael Deeds, et al.. (2013). Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy. Disease Models & Mechanisms. 6(5). 1236–45. 43 indexed citations

Ohmine, Seiga, Karen A. Squillace, Michael Deeds, et al.. (2012). Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging. 4(1). 60–73. 70 indexed citations

10.

Ohmine, Seiga, Allan B. Dietz, Michael Deeds, et al.. (2011). Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells. Stem Cell Research & Therapy. 2(6). 46–46. 24 indexed citations

11.

Deeds, Michael, Jill Anderson, Adam Armstrong, et al.. (2011). Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Laboratory Animals. 45(3). 131–140. 455 indexed citations breakdown →

12.

Rostambeigi, Nassir, Ian R. Lanza, Petras P. Dzeja, et al.. (2010). Unique Cellular and Mitochondrial Defects Mediate FK506-Induced Islet β-Cell Dysfunction. Transplantation. 91(6). 615–623. 48 indexed citations

13.

Anderson, Jill, Michael Deeds, Adam Armstrong, D A Gastineau, & Yogish C. Kudva. (2007). Utilization of a test gradient enhances islet recovery from deceased donor pancreases. Cytotherapy. 9(7). 630–636. 4 indexed citations

14.

Ninova, Dora, Patrick G. Dean, Michael Deeds, & Mark D. Stegall. (2004). A novel model of allograft rejection: immune reconstitution of Rag-1 recipients with 2C transgenic T-cell receptor lymphocytes. Transplant International. 18(1). 101–110. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact